Globally, adolescent girls and young women form nearly half of all new HIV infections. Long-acting PrEP could be a gamechanger for HIV prevention in this key population. The School of Global Health is pleased to share this new comment on long-acting PrEP for adolescents girls and young women in the Lancet HIV.
The article is available in more detail in the link: here, and was co-published by Dr. Wipaporn Natalie Songtaweesin, of the School of Global Health.
